Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06456541
Other study ID # AL60
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date July 2024
Est. completion date January 2029

Study information

Verified date June 2024
Source Abbott Nutrition
Contact Kristen DeLuca
Phone 6145653522
Email kristen.deluca@abbott.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a multi-center, randomized, double-blinded, placebo-controlled food challenge to be conducted in infants and children with confirmed IgE-mediated cow's milk allergy (CMA), followed by a 7-day open feeding of the experimental formula.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 61
Est. completion date January 2029
Est. primary completion date July 2028
Accepts healthy volunteers No
Gender All
Age group 3 Months to 12 Years
Eligibility Inclusion Criteria: - Participant's parent(s) is/are willing for their child to undergo confirmatory testing or must have had at least one of the following within 6 months of enrollment: 1. Physician diagnosis of IgE-mediated CMA, according to the participant's clinical history (e.g. gastrointestinal symptoms, hives, respiratory symptoms or angioedema) AND, detectable serum milk-specific IgE >0.7 kUA/L or positive skin prick test wheal =5 mm; 2. Documentation of milk-specific serum IgE >15 kUA/L or > 5 kUA/L if younger than 1 year; 3. Documented cow's milk skin prick test wheal >10mm; 4. Physician-supervised oral food challenge that elicited immediate, objective, allergic symptoms. - Participant's parent(s) agree for their child to stop oral steroid use within 14 days and antihistamine use within 7 days of confirmation of diagnosis and food challenges. - Participant had followed a strict cow's milk protein-free diet for at least 2 weeks prior to enrollment. - Parent(s) confirm their intention not to administer any products containing cow's milk protein during the study. - Participant is between 3 months and 12 years of age at enrollment. - Participant's parent(s) has voluntarily signed and dated an Informed Consent Form (ICF), approved by an Independent Ethics Committee/Institutional Review Board (IEC/IRB) and provided Health Insurance Portability and Accountability Act (HIPAA) (or other applicable privacy regulation) authorization prior to any participation in the study. Exclusion Criteria: - Participant is partially or exclusively breastfed at the time of enrollment. - Participant is consuming an amino acid-based formula due to failure on an extensively hydrolyzed formula. - Significant chronic medical diseases including major chromosomal or congenital anomalies, gastrointestinal diseases, or abnormalities other than CMA, immunodeficiencies, unstable asthma, asthma treated with biologics (omalizumab or other monoclonal antibody), FPIES, eosinophilic esophagitis, and severe uncontrolled eczema. - Previous severe anaphylactic reaction to cow's milk within the last two years., - An adverse medical history or current condition that is thought by the investigator to have potential for effects on tolerance or the hypoallergenicity test. - Participant has an allergy or intolerance to any ingredient in the study product, as reported by the parent. - Participant is consuming baked milk products.

Study Design


Intervention

Other:
Experimental Extensively Hydrolyzed Formula
Experimental powder formula
Placebo Extensively Hydrolyzed Formula
Placebo powder formula

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Abbott Nutrition

Outcome

Type Measure Description Time frame Safety issue
Primary Food Challenge Reactions Percent of positive food challenge reactions to the experimental formula Food Challenge 1 to Food Challenge 2 (within 14 days of the Food Challenge 1)
Secondary Volume of Experimental Formula Intake Parent completed diaries of Intake Home Feeding Day 1 to Day 7
Secondary Food Intake during Study Parent completed daily food diaries Home Feeding Day 1 to Day 7
Secondary Gastrointestinal Symptoms Parent completed diaries Home Feeding Day 1 to Day 7
Secondary Medication Use Parent completed diaries Home Feeding Day 1 to Day 7
Secondary Food Challenge Positive Reactions Percent of positive food challenge reactions to the experimental formula Home Feeding Day 1 to Day 7
See also
  Status Clinical Trial Phase
Completed NCT02738060 - The Effect of Baked Milk on Cow's Milk Allergy Phase 2
Recruiting NCT02149134 - Evaluation of the Efficacy of a New Infant Formula in Subjects With Cow's Milk Allergy Phase 2
Recruiting NCT01891916 - Effect Of Lactobacillus GG on Atopic March N/A
Completed NCT01634490 - Effects of Different Dietary Regimens on Tolerance Acquisition in Children With Cow's Milk Allergy N/A
Completed NCT01622426 - Tolerance to a New Free Amino Acid-based Formula in Children With IgE or Non-IgE-mediated Cow's Milk Allergy N/A
Completed NCT02466035 - Epigenetic Effects Involved in Children With Cow's Milk Allergy (EPICMA) N/A
Completed NCT02379598 - Effect of Therapy With Aminoacid Based Formula Versus Hydrolyzed Whey Proteins in Children With Cow's Milk Allergy N/A
Completed NCT04330092 - Diagnosis of Cow's Milk Protein Allergy
Not yet recruiting NCT02081651 - Parmigiano-Reggiano Cheese as a Possible Strategy to Acquire Oral Tolerance in Children With Cow's Milk Allergy Phase 3
Completed NCT03462030 - Baked Milk Oral Immunotherapy for Cow's Milk Allergy Phase 2
Completed NCT02465905 - Oral Immunotherapy in Cow's Milk Allergy (CMA) in Children : "Petit Lait" Study N/A
Suspended NCT05731206 - Hypoallergenicity of a Hydrolyzed Protein Infant Formula N/A
Recruiting NCT02062476 - Epigenetic Effects Elicited By Lactobacillus GG In Children With Cow's Milk Allergy Phase 2
Completed NCT01589731 - Polymerized Beta-lactoglobulin Comparative Immunoreactivity N/A
Terminated NCT02405923 - Growth, Safety and Tolerance of a Rice Protein Hydrolysate Formula in Infants With Cow's Milk Protein Allergy N/A
Terminated NCT04910373 - Extensively Hydrolyzed Infant Formula in Infants and Children With Cow's Milk Allergy N/A
Recruiting NCT01968278 - Use of Baked Milk in Oral Immunotherapy for Severe IgE-mediated Cow's Milk Protein Allergic Patients N/A
Withdrawn NCT01470768 - Evaluation of Fatty Acid Levels and Growth in Infants Fed Amino Acid Based (AA) Formulas N/A
Recruiting NCT05883384 - Validity of Cow's Milk-related Symptom Score Among Children Suspected to Have Cow's Milk Protein Alergy
Completed NCT01901380 - Cow's Milk Allergy and Functional Gastrointestinal Disorders N/A